PAG is a private asset manager for institutional investors. We do not provide investment advice or services for individual retail investors. We do not solicit or contact individual investors via chat, text or social messaging applications.
Youran Dairy, China's Leading Upstream Dairy Operator, Completes an HKD5 Billion Hong Kong Listing
China Youran Dairy Group Limited, China’s largest integrated upstream dairy player by revenue, debuted on the Hong Kong Stock Exchange on Friday, June 18, 2021. Youran’s IPO offering size totaled approximately HKD5.0 billion (US$644 million), giving Youran a total market value of HKD26.5 billion (US$3.4 billion) upon listing. The offering size can be increased to approximately HKD5.7 billion (US$741 million) with exercise of the overallotment option.
PAG Becomes Signatory to United Nations-Supported Principles for Responsible Investment
PAG, a leading Asia-focused private investment firm, today announced that it had become a signatory to the United Nations-supported Principles for Responsible Investment (PRI), as part of its ongoing commitment to Environmental, Social and Governance (ESG) issues. PAG is one of the largest alternative asset managers in Asia to commit to the PRI principles to date.
Edelweiss Group, PAG seal partnership with investment in Edelweiss Wealth Management (EWM)
Edelweiss Group, India’s leading diversified financial services conglomerate, and PAG, the leading Asia-focused investment group, today announced an investment by PAG’s private equity strategy in Edelweiss Wealth Management (EWM). This partnership will result in unlocking long-term value for shareholders and accelerating business growth.
REX signs binding agreement with PAG on funding for domestic jet operations
Rex today announced that it had signed an agreement with PAG Regulus Holdings Pte Ltd (PAG), a subsidiary of leading Asia-Pacific focused investment firm PAG that will see an investment by PAG of up to AUD150 million to be used exclusively to support the launch of Rex’s domestic jet operations scheduled to commence on 1 March 2021 (Funding).
PAG, a leading Asia-focused private equity firm, announced today that along with consortium partners CX Partners and Samara Capital, it had reached an agreement to acquire a controlling stake in Anjan Drug Pvt. Ltd., a Chennai-based manufacturer of active pharmaceutical ingredients (API).